Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis (Q40547967)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2004
edit
Language Label Description Also known as
English
Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis
scientific article published on June 2004

    Statements

    Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis (English)
    Malucchi S
    Gilli F
    Bottero R
    Di Sapio A
    Capobianco M
    Bertolotto A
    1 June 2004
    2031-2037

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit